Literature DB >> 32227190

Heritable arrhythmias associated with abnormal function of cardiac potassium channels.

Lia Crotti1,2,3,4, Katja E Odening5,6,7, Michael C Sanguinetti8.   

Abstract

Cardiomyocytes express a surprisingly large number of potassium channel types. The primary physiological functions of the currents conducted by these channels are to maintain the resting membrane potential and mediate action potential repolarization under basal conditions and in response to changes in the concentrations of intracellular sodium, calcium, and ATP/ADP. Here, we review the diversity and functional roles of cardiac potassium channels under normal conditions and how heritable mutations in the genes encoding these channels can lead to distinct arrhythmias. We briefly review atrial fibrillation and J-wave syndromes. For long and short QT syndromes, we describe their genetic basis, clinical manifestation, risk stratification, traditional and novel therapeutic approaches, as well as insights into disease mechanisms provided by animal and cellular models. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Long QT syndrome; Potassium channels; Short QT syndrome; Sudden cardiac death

Year:  2020        PMID: 32227190     DOI: 10.1093/cvr/cvaa068

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  9 in total

1.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Back Sternick Eduardo; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong-Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti Mac Intyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Pablo Ochoa Juan; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  J Arrhythm       Date:  2022-05-31

2.  Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K+ channels for atrial fibrillation treatment.

Authors:  Shira Burg; Shir Shapiro; Asher Peretz; Elvira Haimov; Boris Redko; Adva Yeheskel; Luba Simhaev; Hamutal Engel; Avi Raveh; Ariel Ben-Bassat; Michael Murninkas; Rotem Polak; Yoni Haitin; Yoram Etzion; Bernard Attali
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-15       Impact factor: 12.779

3.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Eduardo Back Sternick; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti MacIntyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Juan Pablo Ochoa; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  Europace       Date:  2022-09-01       Impact factor: 5.486

4.  Mutation location and IKs regulation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region.

Authors:  Peter J Schwartz; Cristina Moreno; Maria-Christina Kotta; Matteo Pedrazzini; Lia Crotti; Federica Dagradi; Silvia Castelletti; Kristina H Haugaa; Isabelle Denjoy; Maria A Shkolnikova; Paul A Brink; Marshall J Heradien; Sandrine R M Seyen; Roel L H M G Spätjens; Carla Spazzolini; Paul G A Volders
Journal:  Eur Heart J       Date:  2021-12-07       Impact factor: 29.983

5.  COVID-19 pandemia and inherited cardiomyopathies and channelopathies: a short term and long term perspective.

Authors:  Giuseppe Limongelli; Lia Crotti
Journal:  Orphanet J Rare Dis       Date:  2020-06-22       Impact factor: 4.123

6.  Inherited conditions of arrhythmia: translating disease mechanisms to patient management.

Authors:  Silvia G Priori; Carol Ann Remme
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

Review 7.  Mitochondrial Potassium Channels as Druggable Targets.

Authors:  Antoni Wrzosek; Bartłomiej Augustynek; Monika Żochowska; Adam Szewczyk
Journal:  Biomolecules       Date:  2020-08-18

8.  KCNQ1-deficient and KCNQ1-mutant human embryonic stem cell-derived cardiomyocytes for modeling QT prolongation.

Authors:  Yuanxiu Song; Tianwei Guo; Youxu Jiang; Min Zhu; Hongyue Wang; Wenjing Lu; Mengqi Jiang; Man Qi; Feng Lan; Ming Cui
Journal:  Stem Cell Res Ther       Date:  2022-06-28       Impact factor: 8.079

9.  Syndromic disorders caused by gain-of-function variants in KCNH1, KCNK4, and KCNN3-a subgroup of K+ channelopathies.

Authors:  Karen W Gripp; Sarah F Smithson; Ingrid J Scurr; Julia Baptista; Anirban Majumdar; Germaine Pierre; Maggie Williams; Lindsay B Henderson; Ingrid M Wentzensen; Heather McLaughlin; Lisette Leeuwen; Marleen E H Simon; Ellen van Binsbergen; Mary Beth P Dinulos; Julie D Kaplan; Anne McRae; Andrea Superti-Furga; Jean-Marc Good; Kerstin Kutsche
Journal:  Eur J Hum Genet       Date:  2021-02-16       Impact factor: 4.246

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.